Study of how a liposomal antifungal behaves in sick patients
Part of Blood & lymphatic clinical trials.
This trial studies how liposomal amphotericin B (a drug used to treat serious fungal infections) moves through the body in people who are critically ill versus those who are not. It may help doctors choose safer and more accurate dosing for patients with blood-related illnesses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated with liposomal amphotericin B (L-AmB)
- You are admitted to an ICU or a hematology ward
- You are not designated as DNR 2 or DNR 3
- You are not pregnant and not breastfeeding
- You have not previously had an intolerance or allergy to L-AmB
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how two antifungal medicines (anidulafungin and caspofungin) behave in the blood of critically ill ICU patients. It may help doctors better understand which dosing works best when patients have low blood protein levels or fluid leakage.
This trial studies how the body processes the antifungal drug liposomal amphotericin B (L-AmB) in patients on ECMO (a heart-lung machine). The goal is to find the right dose for treating invasive fungal infections in ICU patients who need ECMO support.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This study measures how the body processes a common antifungal medicine (liposomal amphotericin B) in patients who have a serious fungal infection and are also undergoing plasma exchange—a treatment that filters and cleans the blood. Understanding these drug levels may help doctors give better doses.
This study looks at how well a medicine called liposomal amphotericin B works for treating serious fungal infections in people who have had a solid organ transplant. It may help doctors understand the best way to use this medicine for patients like you.
This trial tests amphotericin B (an antifungal medication) in patients with blood cancers who develop a fungal infection despite already taking antifungal preventive medicine. The study aims to see if this medication can treat these hard-to-treat infections.
Hear when a new Critically Ill Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.